Literature DB >> 24107215

Evaluation of Crimean-Congo hemorrhagic fever virus infection in children.

Murat Kızılgun1, Aslınur Ozkaya-Parlakay, Hasan Tezer, Belgin Gulhan, Saliha Kanik-Yüksek, Elif Celikel, Bahattin Tunc.   

Abstract

Crimean-Congo haemorrhagic fever (CCHF) is a fatal viral infection and an important public health issue in Turkey because of its high case fatality rate. Severity criteria of CCHF were defined previously in adults on the basis of epidemiological, clinical, and laboratory findings,. This study evaluated the course of CCHF in children. Between January, 2009, and November, 2012, 41 patients aged between 1 and 17 years (mean 9.78 ± 4.85) with a diagnosis of CCHF were included in the study. According to results of our study, Turkish pediatric patients had a milder course of CCHF.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24107215     DOI: 10.1089/vbz.2013.1297

Source DB:  PubMed          Journal:  Vector Borne Zoonotic Dis        ISSN: 1530-3667            Impact factor:   2.133


  3 in total

1.  Elevated Human Crimean-Congo Hemorrhagic Fever Virus Seroprevalence in Khashm el Girba, Eastern Sudan.

Authors:  Paul Rahden; Awadalkareem Adam; Angela Mika; Christian Jassoy
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

2.  Development and evaluation of a real-time RT-qPCR for detection of Crimean-Congo hemorrhagic fever virus representing different genotypes.

Authors:  Anne J Jääskeläinen; Hannimari Kallio-Kokko; Aykut Ozkul; Hurrem Bodur; Gulay Korukruoglu; Mehrdad Mousavi; Patel Pranav; Antti Vaheri; Ali Mirazimi; Olli Vapalahti
Journal:  Vector Borne Zoonotic Dis       Date:  2014-12       Impact factor: 2.133

3.  Ribavirin use in pediatric patients with Crimean Congo Hemorrhagic Fever: is it really necessary?

Authors:  Hasan Tezer; Aslinur Ozkaya-Parlakay; Belgin Gulhan; Saliha Kanik-Yuksek
Journal:  Braz J Infect Dis       Date:  2016-02-02       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.